WO2001089455A3 - System and method for assessing the performance of a pharmaceutical agent delivery system - Google Patents

System and method for assessing the performance of a pharmaceutical agent delivery system Download PDF

Info

Publication number
WO2001089455A3
WO2001089455A3 PCT/US2001/016398 US0116398W WO0189455A3 WO 2001089455 A3 WO2001089455 A3 WO 2001089455A3 US 0116398 W US0116398 W US 0116398W WO 0189455 A3 WO0189455 A3 WO 0189455A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical agent
performance
assessing
agent delivery
electrodes
Prior art date
Application number
PCT/US2001/016398
Other languages
French (fr)
Other versions
WO2001089455A2 (en
Inventor
Adam J Simon
Original Assignee
Merck & Co Inc
Adam J Simon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc, Adam J Simon filed Critical Merck & Co Inc
Priority to CA002409603A priority Critical patent/CA2409603A1/en
Priority to AU2001264759A priority patent/AU2001264759B2/en
Priority to EP01939219A priority patent/EP1292359A4/en
Priority to JP2001585701A priority patent/JP2004532654A/en
Priority to AU6475901A priority patent/AU6475901A/en
Publication of WO2001089455A2 publication Critical patent/WO2001089455A2/en
Publication of WO2001089455A3 publication Critical patent/WO2001089455A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0002General or multifunctional contrast agents, e.g. chelated agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/20Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303Constructional details
    • A61N1/306Arrangements where at least part of the apparatus is introduced into the body

Abstract

A system and method for assessing the performance of a system for delivering a pharmaceutical agent to a portion of a body. A pair of electrodes are applied to the portion of the body. A pharmaceutical agent is infused into the portion of the body and the electrodes are energized by a signal generator, electrically stimulating the portion of the body. The voltage and current delivered to the portion of the body are measured using a data acquisition system thereby generating electrical parameter data. An immune response, gene expression level or other biological response to the pharmaceutical agent is measured and the electrical test data is correlated with the biological response to assess the performance of the system.
PCT/US2001/016398 2000-05-22 2001-05-22 System and method for assessing the performance of a pharmaceutical agent delivery system WO2001089455A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA002409603A CA2409603A1 (en) 2000-05-22 2001-05-22 System and method for assessing the performance of a pharmaceutical agent delivery system
AU2001264759A AU2001264759B2 (en) 2000-05-22 2001-05-22 System and method for assessing the performance of a pharmaceutical agent delivery system
EP01939219A EP1292359A4 (en) 2000-05-22 2001-05-22 System and method for assessing the performance of a pharmaceutical agent delivery system
JP2001585701A JP2004532654A (en) 2000-05-22 2001-05-22 Drug administration system performance evaluation system and method
AU6475901A AU6475901A (en) 2000-05-22 2001-05-22 System and method for assessing the performance of a pharmaceutical agent delivery system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20612100P 2000-05-22 2000-05-22
US60/206,121 2000-05-22

Publications (2)

Publication Number Publication Date
WO2001089455A2 WO2001089455A2 (en) 2001-11-29
WO2001089455A3 true WO2001089455A3 (en) 2002-08-29

Family

ID=22765067

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/016398 WO2001089455A2 (en) 2000-05-22 2001-05-22 System and method for assessing the performance of a pharmaceutical agent delivery system

Country Status (6)

Country Link
US (1) US6928318B2 (en)
EP (1) EP1292359A4 (en)
JP (1) JP2004532654A (en)
AU (2) AU6475901A (en)
CA (1) CA2409603A1 (en)
WO (1) WO2001089455A2 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030074679A1 (en) * 2000-12-12 2003-04-17 Schwartz Robert J. Administration of nucleic acid sequence to female animal to enhance growth in offspring
ITTO20010534A1 (en) * 2001-06-04 2002-12-04 Igea Srl ELECTROPORATION DEVICE AND METHOD THAT REDUCES MUSCLE CONTRACTION AND SENSATION OF PAIN.
US8209006B2 (en) * 2002-03-07 2012-06-26 Vgx Pharmaceuticals, Inc. Constant current electroporation device and methods of use
CA2477870C (en) * 2002-03-07 2018-04-03 Advisys, Inc. Electrode assembly for constant-current electroporation and use
US7245963B2 (en) * 2002-03-07 2007-07-17 Advisys, Inc. Electrode assembly for constant-current electroporation and use
US20040014645A1 (en) * 2002-05-28 2004-01-22 Advisys, Inc. Increased delivery of a nucleic acid construct in vivo by the poly-L-glutamate ("PLG") system
US20040204358A1 (en) * 2003-01-28 2004-10-14 Advisys, Inc. Reducing culling in herd animals growth hormone releasing hormone (GHRH)
WO2005058889A2 (en) * 2003-12-18 2005-06-30 Owen Holding Ltd. Biological active blood serum obtained by electrostimulation
US20090005333A1 (en) * 2004-01-26 2009-01-01 Vgx Pharmaceuticlas, Inc. Reducing culling in herd animals growth hormone releasing hormone (ghrh)
BRPI0512607A (en) * 2004-06-24 2008-03-25 Sphergen device for transferring molecules to cells that uses an electric force
US8386029B2 (en) * 2005-03-31 2013-02-26 Encore Medical Asset Corporation Apparatus for electrotherapy drug delivery with added impurities
WO2006112870A1 (en) * 2005-04-19 2006-10-26 Excellin Life Sciences, Inc. Device and method for controlled electroporation and molecular delivery in cells and tissue
US8114070B2 (en) * 2005-06-24 2012-02-14 Angiodynamics, Inc. Methods and systems for treating BPH using electroporation
US20060293725A1 (en) * 2005-06-24 2006-12-28 Boris Rubinsky Methods and systems for treating fatty tissue sites using electroporation
US20060293730A1 (en) * 2005-06-24 2006-12-28 Boris Rubinsky Methods and systems for treating restenosis sites using electroporation
US20070088331A1 (en) * 2005-08-18 2007-04-19 Transcutaneous Technologies Inc. Method and apparatus for managing active agent usage, and active agent injecting device
US20070078445A1 (en) * 2005-09-30 2007-04-05 Curt Malloy Synchronization apparatus and method for iontophoresis device to deliver active agents to biological interfaces
US8226811B2 (en) 2005-11-02 2012-07-24 May-Ruben Technologies, Inc. High impedance system for generating electric fields and method of use
US20070232984A1 (en) * 2006-03-30 2007-10-04 Michael Lovell Hand-held electrical stimulation device
ITNA20060082A1 (en) * 2006-06-30 2008-01-01 Renato Cappelletti "MULTI-OUTPUT ELECTRO-STIMULATOR, WITH INTEGRATED AND HOMOGENEOUS ELECTRIC FIELD".
US20080077076A1 (en) * 2006-08-29 2008-03-27 Transcutaneous Technologies Inc. Iontophoresis device and method for operation with a usb (universal serial bus) power source
KR20090060279A (en) * 2006-09-05 2009-06-11 티티아이 엘뷰 가부시키가이샤 Non-destructive systems, devices, and methods for evaluating iontophoresis drug delivery devices
US7998745B2 (en) * 2006-09-05 2011-08-16 Tti Ellebeau, Inc. Impedance systems, devices, and methods for evaluating iontophoretic properties of compounds
KR101421760B1 (en) * 2006-10-17 2014-07-22 브이지엑스 파머시우티컬즈, 인크. Electroporation devices and methods of using same for electroporation of cells in mammals
KR100730582B1 (en) * 2006-11-20 2007-06-20 아람휴비스(주) An apparatus for iontophoresis
JP5383497B2 (en) 2006-12-01 2014-01-08 Tti・エルビュー株式会社 System and device for powering and / or controlling a device, for example a transdermal delivery device
WO2008087884A1 (en) * 2007-01-16 2008-07-24 Tti Ellebeau, Inc. Method for predicting medicament dose and program therefor
US7803582B2 (en) * 2007-03-17 2010-09-28 Hongzhan Xu Recombinant vector and use in gene therapy
EP2209490A4 (en) * 2007-11-14 2013-01-09 VGX Pharmaceuticals LLC Antibody production elicited by a dna vaccine delivered by electroporation
US8816205B2 (en) * 2009-04-03 2014-08-26 Ppc Broadband, Inc. Conductive elastomer and method of applying a conductive coating to a cable
US20130011909A1 (en) * 2011-06-30 2013-01-10 Texas Tech University System Methods and composition to enhance production of fully functional p-glycoprotein in pichia pastoris
US10161390B2 (en) * 2013-03-14 2018-12-25 Lawrence Livermore National Security, Llc Bidirectional shape memory device
KR20160119093A (en) * 2014-02-04 2016-10-12 로레알 Electric mask comprising at least two compartments
WO2016112315A2 (en) 2015-01-09 2016-07-14 President And Fellows Of Harvard College Nanowire arrays for neurotechnology and other applications
US11768196B2 (en) 2017-07-07 2023-09-26 President And Fellows Of Harvard College Current-based stimulators for electrogenic cells and related methods
US20200292482A1 (en) * 2017-11-01 2020-09-17 President And Fellows Of Harvard College Electronic circuits for analyzing electrogenic cells and related methods
EP4168172A1 (en) 2020-06-17 2023-04-26 President and Fellows of Harvard College Systems and methods for patterning and spatial electrochemical mapping of cells
CA3187265A1 (en) 2020-06-17 2021-12-23 President And Fellows Of Harvard College Apparatuses for cell mapping via impedance measurements and methods to operate the same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5515848A (en) * 1991-10-22 1996-05-14 Pi Medical Corporation Implantable microelectrode
US5968006A (en) * 1997-11-04 1999-10-19 Genetronics, Inc. Method and apparatus for a combination of electroporation and iontophoresis for the delivery of drugs and genes
US5983131A (en) * 1995-08-11 1999-11-09 Massachusetts Institute Of Technology Apparatus and method for electroporation of tissue

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383529A (en) * 1980-11-03 1983-05-17 Wescor, Inc. Iontophoretic electrode device, method and gel insert
US4406658A (en) * 1981-03-06 1983-09-27 Medtronic, Inc. Iontophoretic device with reversible polarity
US4702732A (en) * 1984-12-24 1987-10-27 Trustees Of Boston University Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands
US5545130A (en) 1992-04-08 1996-08-13 Genetronics, Inc. Flow through electroporation method
US5501662A (en) 1992-05-22 1996-03-26 Genetronics, Inc. Implantable electroporation method and apparatus for drug and gene delivery
US5507724A (en) 1992-07-01 1996-04-16 Genetronics, Inc. Electroporation and iontophoresis apparatus and method for insertion of drugs and genes into cells
US5273525A (en) 1992-08-13 1993-12-28 Btx Inc. Injection and electroporation apparatus for drug and gene delivery
US5439440A (en) 1993-04-01 1995-08-08 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US5702359A (en) 1995-06-06 1997-12-30 Genetronics, Inc. Needle electrodes for mediated delivery of drugs and genes
US5810762A (en) 1995-04-10 1998-09-22 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US5911223A (en) * 1996-08-09 1999-06-15 Massachusetts Institute Of Technology Introduction of modifying agents into skin by electroporation
US5869326A (en) 1996-09-09 1999-02-09 Genetronics, Inc. Electroporation employing user-configured pulsing scheme
US5704908A (en) 1996-10-10 1998-01-06 Genetronics, Inc. Electroporation and iontophoresis catheter with porous balloon
KR100427786B1 (en) 1997-04-03 2004-04-30 일렉트로우펙트 에이에스 Method and device for introducing pharmaceutical drugs and nucleic acids into skeletal muscle
WO1999001175A1 (en) 1997-06-30 1999-01-14 Rhone-Poulenc Rorer S.A. Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo
HUP0004589A3 (en) 1997-06-30 2003-08-28 Centre Nat Rech Scient Improved method for transferring nucleic acid into the striped muscle and combination therefor
CN1261808A (en) 1997-06-30 2000-08-02 罗纳-布朗克罗莱尔股份有限公司 Improved method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor
US6047208A (en) * 1997-08-27 2000-04-04 Becton, Dickinson And Company Iontophoretic controller
CA2337652C (en) * 1998-07-13 2013-03-26 Genetronics, Inc. Skin and muscle-targeted gene therapy by pulsed electrical field

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5515848A (en) * 1991-10-22 1996-05-14 Pi Medical Corporation Implantable microelectrode
US5983131A (en) * 1995-08-11 1999-11-09 Massachusetts Institute Of Technology Apparatus and method for electroporation of tissue
US5968006A (en) * 1997-11-04 1999-10-19 Genetronics, Inc. Method and apparatus for a combination of electroporation and iontophoresis for the delivery of drugs and genes

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BUREAU ET AL.: "Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1474, no. 3, 1 May 2000 (2000-05-01), pages 353 - 359, XP004276575 *
OSHIMA ET AL.: "Targeted gene transfer to corneal endothelium in vivo by electric pulse", GENE THERAPY, vol. 5, no. 10, October 1998 (1998-10-01), pages 1347 - 1354, XP001029779 *
See also references of EP1292359A4 *
ZHANG ET AL: "In vivo transdermal delivery of large molecules by pressure-mediated electroincorporation and electroporation: a novel method for drug and gene delivery", BIOELECTROCHEMISTRY AND BIOENERGISTICS, vol. 42, 1997, pages 283 - 292, XP002950932 *

Also Published As

Publication number Publication date
US6928318B2 (en) 2005-08-09
WO2001089455A2 (en) 2001-11-29
US20020010415A1 (en) 2002-01-24
AU2001264759B2 (en) 2006-06-01
JP2004532654A (en) 2004-10-28
AU6475901A (en) 2001-12-03
EP1292359A4 (en) 2005-03-30
CA2409603A1 (en) 2001-11-29
EP1292359A2 (en) 2003-03-19

Similar Documents

Publication Publication Date Title
WO2001089455A3 (en) System and method for assessing the performance of a pharmaceutical agent delivery system
EP0904801A3 (en) Method of detecting events or conditions in an iontophoretic drug delivery system
FI110309B (en) Apparatus for pulsed iontophoretic drug delivery
EP1163024A4 (en) Delivery of macromolecules into cells
WO2008086018A3 (en) Two-probe bark control device and method for making such
CN101160151B (en) Simultaneous stimulation for low power consumption
BR0308438A (en) Biomedical electrode and method for obtaining and transmitting electrical signals of a patient's electrophysiological or electrobiological origin
EP0823239A3 (en) Bi-level charge pulse apparatus to facilitate nerve location during peropheral nerve block procedures
EP1125549A3 (en) Catheter for generating an electrical map of a chamber of the heart
IL133710A0 (en) Improved method for transferring nucleic acid into the striped muscle and combination thereof
WO2005105201A3 (en) Electrical nerve stimulation device
CN102256663A (en) Optimizing the stimulus current in a surface based stimulation device
WO2006093686A3 (en) Lead electrode for use in an mri-safe implantable medical device
EP1224908A4 (en) Body fat measurement method and device therefor
TW338717B (en) Apparatus and method for electrosurgery
EP0896211A3 (en) Apparatus and method for leak detection
WO2007111542A8 (en) Medical system for monitoring and localisation of electrode leads in the heart
EP0904739A3 (en) Method and apparatus determining electrode/tissue contact
SE9901056D0 (en) Sensor system
DE60040156D1 (en) DEVICE FOR THE ELECTROPORATION OF GENES, PROTEINS OR FOR THE ADMINISTRATION OF MEDICAMENTS
WO2008038241A3 (en) Electrically activated gel array for transdermal drug delivery
WO2006010837A3 (en) Device for transferring molecules to cells using an electric force
GB1432233A (en) Catheter probe
FR2803759B1 (en) ACTIVE IMPLANTABLE MEDICAL DEVICE, IN PARTICULAR A CARDIAC STIMULATOR, DEFIBRILLATOR AND / OR MULTI-SITE DEVICE PROVIDED WITH MEANS OF MEASUREMENT OF TRANSVALVULAR IMPEDANCE
EP2359756A3 (en) Method and system for destroying of undersirable formations in mammalian body

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2409603

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001264759

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2001939219

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001939219

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001939219

Country of ref document: EP